Company: BDRX
Filing Date: 2025-04-11
Form Type: 20-F
Source: 0001214659-25-005742
Chunk: 69

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-04-11
Form: 20-F
Item: Item 19
Chunk 69
---
 other comprehensive income or to an item recognised
directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax credit is calculated on
the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the country where the Company
operates and generates income.

Deferred
taxation

Deferred tax assets and liabilities are recognised where the carrying amount of an
asset or liability in the consolidated statement of financial position differs from its tax base, except for differences arising on:

  the initial recognition of goodwill;  

  the initial recognition of an asset or liability in a transaction                                                                 

  investments in subsidiaries and jointly controlled entities where                                                                     

Recognition of deferred tax assets is restricted to those instances where it is probable
that taxable profit will be available against which the difference can be utilised.

The amount of the asset or liability is determined using tax rates that have been
enacted or substantively enacted by the reporting date and are expected to apply when the deferred tax assets or liabilities are recovered
or settled.

Property,
plant and equipment

Property, plant and equipment is stated at cost, net of accumulated depreciation
and accumulated impairment losses.

Depreciation is provided on all items of property, plant and equipment so as to write
off their carrying value over their expected useful economic lives. It is provided at the following rates:

  Schedule of depreciation rates of property, plant and equipment                                                                           
  Fixtures and fittings                                                – 20%- 25% per annum straight line                                   
  Leasehold improvements                                               – the shorter of 10% per annum straight line or over the lease term  
  Computer equipment                                                   – 25% per annum straight line                                        
  Laboratory equipment                                                 – 15% – 25% per annum straight line                                  
  Right of use asset                                                   – Economic life of contractual relationship                          

2 Critical accounting estimates and
judgements

The preparation of these consolidated financial statements requires the Group to
make estimates, assumptions and judgments that can have a significant impact on the reported amounts of assets and liabilities, revenue
and expenses and related disclosure of contingent assets and liabilities, at the respective dates of our financial statements. The Group
bases its estimates, assumptions and judgments on historical experience and various other factors that we believe to be reasonable under
the circumstances. Actual results may differ from these estimates under different assumptions or conditions. Management evaluates estimates,
assumptions and judgments on a regular basis and makes changes accordingly and discusses critical accounting estimates with the board
of Directors.